<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76554</article-id><article-id pub-id-type="doi">10.7554/eLife.76554</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Gut Microbial Trimethylamine is Elevated in Alcohol-Associated Hepatitis and Contributes to Ethanol-Induced Liver Injury in Mice</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-212453"><name><surname>Helsley</surname><given-names>Robert N</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5000-3187</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-265530"><name><surname>Miyata</surname><given-names>Tatsunori</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265531"><name><surname>Kadam</surname><given-names>Anagha</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149266"><name><surname>Varadharajan</surname><given-names>Venkateshwari</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-261753"><name><surname>Sangwan</surname><given-names>Naseer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265532"><name><surname>Huang</surname><given-names>Emily C.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265533"><name><surname>Banerjee</surname><given-names>Rakhee</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109966"><name><surname>Brown</surname><given-names>Amanda L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212456"><name><surname>Fung</surname><given-names>Kevin K</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149271"><name><surname>Massey</surname><given-names>William</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2087-6048</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265547"><name><surname>Neumann</surname><given-names>Chase</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-149269"><name><surname>Orabi</surname><given-names>Danny</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160869"><name><surname>Osborn</surname><given-names>Lucas J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212451"><name><surname>Schugar</surname><given-names>Rebecca C</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265549"><name><surname>McMullen</surname><given-names>Megan R.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265522"><name><surname>Bellar</surname><given-names>Annette</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265550"><name><surname>Poulsen</surname><given-names>Kyle L.</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-265523"><name><surname>Kim</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265551"><name><surname>Pathak</surname><given-names>Vai</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265552"><name><surname>Mrdjen</surname><given-names>Marko</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212462"><name><surname>Anderson</surname><given-names>James T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-38701"><name><surname>Willard</surname><given-names>Belinda</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265524"><name><surname>McClain</surname><given-names>Craig J.</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265525"><name><surname>Mitchell</surname><given-names>Mack</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265526"><name><surname>McCullough</surname><given-names>Arthur J.</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265527"><name><surname>Radaeva</surname><given-names>Svetlana</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265528"><name><surname>Barton</surname><given-names>Bruce</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7878-8895</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-265529"><name><surname>Szabo</surname><given-names>Gyongyi</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-39729"><name><surname>Dasarathy</surname><given-names>Srinivasan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1774-0104</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212468"><name><surname>Garcia-Garcia</surname><given-names>Jose Carlos</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-265543"><name><surname>Rotroff</surname><given-names>Daniel M.</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109976"><name><surname>Allende</surname><given-names>Daniela S</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-163828"><name><surname>Wang</surname><given-names>Zeneng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-23498"><name><surname>Hazen</surname><given-names>Stanley L</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-250226"><name><surname>Nagy</surname><given-names>Laura E</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-51657"><name><surname>Brown</surname><given-names>Jonathan Mark</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2708-7487</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Cardiovascular and Metabolic Sciences</institution>, <institution>Cleveland Clinic Lerner College of Medicine</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Cleveland Clinic</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Research Core Services</institution>, <institution>Cleveland Clinic Lerner College of Medicine</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><institution>University of Louisville</institution>, <addr-line><named-content content-type="city">Louisville</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>The University of Texas Southwestern Medical Center</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>National Institute of Health</institution>, <addr-line><named-content content-type="city">Bethesda</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution>Beth Israel Deaconess Medical Center</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution content-type="dept">Life Sciences Transformative Platform Technologies</institution>, <institution>Procter and Gamble</institution>, <addr-line><named-content content-type="city">Cincinatti</named-content></addr-line>, <country>United States</country></aff><aff id="aff10"><institution content-type="dept">Department of Cellular and Molecular Medicine</institution>, <institution>Cleveland Clinic Lerner College of Medicine</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff><aff id="aff11"><institution content-type="dept">IDepartment of Inflammation and Immunity</institution>, <institution>Cleveland Clinic, Lerner Research Institute</institution>, <addr-line><named-content content-type="city">Cleveland</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-30545"><name><surname>Ardehali</surname><given-names>Hossein</given-names></name><role>Reviewing editor</role><aff><institution>Northwestern University</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>brownm5@ccf.org</email> (JB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>27</day><month>01</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e76554</elocation-id><history><date date-type="received"><day>21</day><month>12</month><year>2021</year></date><date date-type="accepted"><day>31</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Helsley et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Helsley et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76554-v2.pdf"/><abstract><p>There is mounting evidence that microbes resident in the human intestine contribute to diverse alcohol-associated liver diseases (ALD) including the most deadly form known as alcohol-associated hepatitis (AH). However, mechanisms by which gut microbes synergize with excessive alcohol intake to promote liver injury are poorly understood. Furthermore, whether drugs that selectively target gut microbial metabolism can improve ALD has never been tested. We used liquid chromatography tandem mass spectrometry to quantify the levels of microbe and host choline co-metabolites in healthy controls and AH patients, finding elevated levels of the microbial metabolite trimethylamine (TMA) in AH. In subsequent studies, we treated mice with non-lethal bacterial choline TMA lyase (CutC/D) inhibitors to blunt gut microbe-dependent production of TMA in the context of chronic ethanol administration. Indices of liver injury were quantified by complementary RNA sequencing, biochemical, and histological approaches. In addition, we examined the impact of ethanol consumption and TMA lyase inhibition on gut microbiome structure via 16S rRNA sequencing. We show the gut microbial choline metabolite trimethylamine (TMA) is elevated in AH patients and correlates with reduced hepatic expression of the TMA oxygenase flavin-containing monooxygenase 3 (FMO3). Provocatively, we find that small molecule inhibition of gut microbial CutC/D activity protects mice from ethanol-induced liver injury. CutC/D inhibitor-driven improvement in ethanol-induced liver injury is associated with distinct reorganization of the gut microbiome and host liver transcriptome. The microbial metabolite TMA is elevated in patients with AH, and inhibition of TMA production from gut microbes can protect mice from ethanol-induced liver injury.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Robert N Helsley, reports being a paid consultant for the University of Cincinnati..</p></fn><fn fn-type="conflict" id="conf3"><p>Kyle L. Poulsen, Grant support from NIH.</p></fn><fn fn-type="conflict" id="conf4"><p>Gyongyi Szabo, G.S. reports being a paid consult for Allergan, Alnylam, Arrow, Durcect Corporation, Generon, Glympse Bio, Terra Firma, Quest Diagnostics, Pandion Therapeutics, Surrozen, and Zomagen. G.S. has received grants from Gilead, Genfit, Intercept, Novartis, SignaBlok, and Shire; she also holds intellectual property rights with Up to Date..</p></fn><fn fn-type="conflict" id="conf5"><p>Jose Carlos Garcia-Garcia, is an employee of The Procter &amp; Gamble Co..</p></fn><fn fn-type="conflict" id="conf6"><p>Daniela S Allende, Kaiser Permanente (CME lecture sessions)Advisory Board for Incyte (on treatment of cholangiocarcinoma).</p></fn><fn fn-type="conflict" id="conf7"><p>Zeneng Wang, Z.W. report being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics.  Z.W. reports being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Zehna Therapeutics, Cleveland Heart Lab, a wholly owned subsidiary of Quest Diagnostics, and Procter &amp; Gamble..</p></fn><fn fn-type="conflict" id="conf8"><p>Stanley L Hazen, S.L.H. report being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics.  S.L.H. reports being a paid consultant for Zehna Therapeutics, having received research funds from Zehna Therapeutics, Procter &amp; Gamble, and Roche Diagnostics. S.L.H. report being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Zehna Therapeutics, Cleveland Heart Lab, a wholly owned subsidiary of Quest Diagnostics, and Procter &amp; Gamble..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mice were maintained in an Association for the Assessment and Accreditation of Laboratory Animal Care, International-approved animal facility. All experimental protocols were approved by the institutional animal care and use committee (IACUC) at the Cleveland Clinic.</p></fn><fn fn-type="other"><p>Human subjects: Patients with AH were classified as moderate (MELD &lt; 20, n=112) and severe (MELD {greater than or equal to}20, n=152) according to the MELD score at admission as part of either of two independent clinical trials (ClincalTrials.gov identifier # NCT01809132 and NCT03224949) or the NOAC biorepository. These studies were approved by the Institutional Review Boards of all 4 participating institutions and all study participants consented prior to collection of data and blood samples. Written informed consent was obtained from each patient included in the study and the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the Institutional Review Boards at Johns Hopkins Medical Institutions.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code GSE157681.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Brown JM</collab><collab>Helsley R</collab><collab>Kadam A</collab><collab>Neumann C</collab></person-group><year iso-8601-date="2021">2021</year><source>The Gut Microbe-Derived Metabolite Trimethylamine is a Biomarker of and Therapeutic Target in Alcohol-Associated Liver Disease</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157681">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE157681</ext-link><comment>NCBI Gene Expression Omnibus, GSE157681</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-76554-supp-v2.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>